?:abstract
|
-
From the Scope: The scope of this document is to provide EU/EEA [European Union/European Economic Area] Member States and the UK with technical guidance for estimating the prevalence of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] infected cases, through a cross sectional study design based on pooled sampling for RT-PCR [Reverse Transcription-Polymerase Chain Reaction] testing on a random population sample The proposed methodology is for surveillance purposes and does not address pooled testing for clinical (i e diagnostic) or public health (e g contact tracing, infection prevention and control, screening) management of individuals The goal is to provide a tool to monitor the activity of the disease with high efficiency in terms of laboratory resources The methodology provides a way to estimate prevalence from the results of a pooled RT-PCR test, without the need to identify individual test results, and the statistical foundation for the strategy COVID-19 (Disease);Health--Testing;European Union
|